This side event therefore aims to underscore the critical need for dedicated CV health action plans as strategic frameworks to guide national efforts in preventing and managing cardiovascular disease. It will also provide a timely platform to introduce WHF’s Framework, offering countries a practical and adaptable guide to develop and scale up effective national CV health action plans. By fostering collaboration between policymakers, public health experts, and key stakeholders, we aim to catalyze sustained, long-term action to prioritize cardiovascular health and strengthen national health systems worldwide.
Limited access to affordable and quality-assured hypertension medicines remains a significant barrier to reducing cardiovascular disease (CVD) burden worldwide. Many low- and middle-income countries (LMICs) face challenges related to supply chain inefficiencies, high medication costs and inadequate integration of hypertension treatment within universal health coverage (UHC) frameworks. This side event, co-organized by WHF and RTSL, will bring together policymakers, healthcare providers and global health experts to discuss the critical role of hypertension medicines in reducing CVD mortality and the systemic barriers that hinder their availability. The event will highlight country experiences, policy interventions and innovative financing mechanisms to improve equitable access to hypertension medicines globally.